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Summary
Background: Bronchial asthma is the most frequent chronic childhood disease and can have
a marked impact on educational development, activities and quality of life. The AIRMAG
survey provides an opportunity to assess asthma and its impact in children in North Africa.
Objective: To describe the prevalence, burden and management of asthma in children in
the Maghreb.
Methods: A general population sample was generated using a stratiﬁed sampling method
based on randomly-generated lists of telephone numbers. The target sample consisted of
10 000 households in each country, which were contacted by telephone. A structured inter-
view was proposed. Two screening questions were asked to identify subjects with asthma.
Children who met these criteria were then questioned in more detail about their asthma.
Results: Of 30 350 households contacted, 1090 subjects with asthma were identiﬁed, of
whom 248 were aged under sixteen and interviewed by proxy. The prevalence of paediatric
asthma ranged from 3.5% in Tunisia to 4.4% in Morocco. 22.8% of children were rated as se-
vere persistent and 30.9% as intermittent. Asthma control was adequate in 7.6% of children
and unacceptable in 46.2%. Control was best in Tunisia and worst in Morocco. 12.2% had
been hospitalised for their asthma in the previous year and 32.9% had needed to attend an
emergency department. Short-acting b-agonists were used by 52.8% of children and prophy-
lactic inhaled corticosteroids (alone or in association with long-acting b-agonists) by 27.0%.
Conclusions: Asthma has a major impact on the lives of children with asthma in the
Maghreb. This could be improved by offering more appropriate care as recommended in
the GINA guidelines.
© 2009 Published by Elsevier Ltd.
Introduction
Asthma is the most frequent chronic illness encountered
in children. The ISAAC survey has used a standardised
*Tel: +971 4 332 1070; fax: +971 4 332 3071
E-mail address: abdelkader.a.el-hasnaoui@gsk.com
(A. El Hasnaoui).
methodology to estimate the prevalence of wheezing in
the past twelve months in a large number of countries
around the world 1. Although high prevalence rates were
found in Western Europe (16.1%) and North America (24.2%),
prevalence in many developing countries was much lower 1.
Concerning the Maghreb countries of North Africa, three
centres in Morocco and one in Algeria participated in the
0954-6111/$ see front matter © 2009 Published by Elsevier Ltd.
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ISAAC project, providing prevalence rates of 7.8% in Algeria
and 7.5% in Morocco 1. However, ﬁndings such as this only
provide a partial picture of the burden of paediatric asthma
in this region, due to the limited number of participating
centres, which were restricted to urban areas, to the
narrow age group concerned (13 14 year olds), and to the
fact that the ISAAC study did not attempt to address the
issues of asthma severity and management.
Moreover, the ﬁfteen years since the time of the ISAAC
study (1994 1995) have seen important demographic and
lifestyle changes in the Maghreb that may inﬂuence the
burden of asthma in children. Indeed a reiteration of the
ISAAC study in 1999 2000 revealed a signiﬁcant increase in
the proportion of schoolchildren with asthma in Casablanca
and Marrakech 2. In contrast, earlier studies suggested
lower prevalence rates than those observed in the ISAAC
study. For example, a survey of secondary schoolchildren in
Rabat dating from 1986, in which cases were ascertained
by respiratory function tests estimated the cumulative
prevalence of asthma to be 3.4±0.9% 3. Another early report
from 1984 1985 in the Daira de Che´raga region in the
urbanised coastal plain of Algeria provided a very low
estimate of the prevalence of paediatric asthma (1.34%) 4.
A contemporary national Tunisian school survey conducted
in 1985 estimated the prevalence of childhood asthma
to be 2.4% 5.
It is important to update the available information on the
burden of paediatric asthma, to extend this to the general
population of Maghreb countries, and to collect data on
the impact and management of asthma in children in order
to plan appropriate allocation of healthcare resources. For
this reason, we conducted a general population survey,
AIRMAG, to estimate the prevalence, burden, impact and
management of asthma based on the methodology of the
Asthma Insights and Reality surveys (AIR), which has been
widely used over the past decade in other regions of
the world 6. The AIRMAG survey provided prevalence rates
for paediatric asthma in a general population sample of
children aged under sixteen years, as well as information on
the impact of burden of asthma in children in the Maghreb.
The present article reports these data, corresponding
data for adults being described in detail elsewhere in
this supplement 7,8.
Methods
This was a cross-sectional epidemiological survey of asthma
conducted in a random sample of the general population of
Algeria, Morocco and Tunisia between January 2008 and May
2008. The methodology of the study has been described in
detail in an accompanying article in this supplement 8, to
which the reader is referred for more information. A brief
summary is provided hereunder.
A sample of the general population in each of the
three participating countries was generated using a random
stratiﬁed sampling method based on randomly-generated
lists of telephone numbers. The target sample of the
study consisted of 10 000 individuals in each country.
The study population was divided into an adult group
(aged sixteen and over) and a paediatric group (less than
sixteen years).
Households were contacted by ringing each number
in the list consecutively. Each number was dialled up
to ten times in case of non-response before bring
considered a contact failure. After ten calls, outcomes
were categorised as interview, formal refusal, not a valid
number (out of service, not a household, or no response
after ten calls). Telephone interviews were conducted by
seventeen local interviewers (seven for Tunisia, ﬁve for
Morocco and ﬁve for Algeria). Interviewees could choose
the language in which they preferred to respond. The
CAPI (Computer Assisted Personal Interview) method and
CONVERSO® software (developed by Conversoft® France)
were used for the interview. Respondents were ﬁrst asked
if they were willing to participate in a questionnaire
about health in general. If so, information was requested
on the household structure (number in family: members,
gender and age). The household member to answer
the questionnaire was then selected randomly by the
CAPI. In the case of children, the parent answered the
questionnaire.
Two screening questions were asked to identify subjects
fulﬁlling diagnostic criteria for asthma, relating to occur-
rence of asthma symptoms and use of asthma treatments
Subjects responding positively to either of the questions
were considered as having asthma for the purposes of this
study. During a second step, subjects who met these criteria
were then questioned in more detail to collect information
on the frequency and severity of symptoms, impact
on activities of everyday life, treatments, monitoring,
asthma control and knowledge about asthma. Since the
Asthma Control Test 9,10 has not been validated in children,
information on asthma control was derived indirectly from
answers to questions relating to the GINA criteria 11 for
asthma control, however it was not possible to evaluate
pulmonary function, since respiratory function testing was
not possible in the context of a general population study
such as AIRMAG.
For the ﬁve remaining criteria, if all were fulﬁlled the
subject was classiﬁed as controlled, if one or two criteria
were not fulﬁlled the subject was classiﬁed as partially
controlled and if more than two criteria were unfulﬁlled
the subject was classiﬁed as uncontrolled. Severity was
assessed using an adaptation of the severity score based
on the classiﬁcation put forward by the GINA (Global
Initiative on Asthma), that had been used in the previous
AIR studies 6.
Inter-group comparisons were performed with the c2 test
or Fisher’s exact test for categorical variables and Student’s
t-test for continuous variables (corrected using the Welch-
Satterthwaite equation in case of heterogeneous variance).
Two-sided tests were used throughout and a probability
level of p < 0.05 was considered signiﬁcant. All data were
controlled, validated and analysed centrally (Kappa Sante´,
Paris, France) using SAS software, version 9.1 (SAS Institute,
Cary, USA).
Results
Study population
The number of subjects available for interview ranged from
10 015 in Algeria to 10 284 in Tunisia. These included 2 589
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Subjects interviewed
N = 10 015
Children
N = 2 589 (25.9%)
Fulfil asthma criteria
N = 106 (4.09%)
Asthmaquestionnaires
N = 82 (77.4%)
Subjects interviewed
N = 10 051
Children
N = 2 077 (20.7%)
Fulfil asthma criteria
N = 91 (4.38%)
Asthmaquestionnaires
N = 74 (81.3%)
Subjects interviewed
N = 10 284
Children
N = 2 870 (27.9%)
Fulfil asthma criteria
N = 102 (3.55%)
Asthmaquestionnaires
N = 92 (90.2%)
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Fig. 1. Children identiﬁed with asthma in the three participating countries.
Percentages are calculated with respect to the previous box on the diagram
in each case.
Table 1. Asthma history
Algeria
(N = 82)
Morocco
(N = 74)
Tunisia
(N = 92)
Age
Mean±SD
Median [Range]
4 years
5 9 years
10 12 years
>12 years
7.6±4.4
7.5 [1 15]
28 (34.2%)
26 (31.7%)
13 (15.9%)
15 (18.3%)
9.0±4.6
9.5 [1 15]
15 (20.3%)
22 (29.7%)
14 (18.9%)
23 (31.1%)
8.6±3.9
9 [1 15]
16 (17.4%)
34 (37.0%)
23 (25.0%)
19 (20.6%)
Gender
Girls
Boys
30 (36.6%)
52 (63.4%)
39 (52.7%)
35 (47.3%)
33 (35.9%)
59 (64.1%)
Age at diagnosis
Mean±SD
Median [Range]
2.8±2.8
2 [0.1 13]
3.2±3.2
2 [0.1 14]
3.9±3.5
3 [0.1 14]
Time since diagnosis
Mean±SD
Median [Range]
4.8±3.5
4 [0 14]
5.8±4
5 [0 14.8]
4.8±3.4
4 [0 13]
Diagnosis provided by:
General practitioner
Specialist
Emergency room
26 (32.1%)
45 (55.6%)
9 (11.1%)
11 (14.9%)
63 (85.2%)
0 (0%)
33 (36.3%)
43 (47.3%)
5 (5.5%)
Presenting symptoms a
Persistent cough
Breathlessness
Wheezing
Cold stress dyspnoea
Chest tightness
Persistent cold
Night awakenings
Blocked nose
Cough with phlegm
Other symptoms
36 (43.9%)
25 (30.5%)
26 (31.7%)
29 (35.4%)
26 (31.7%)
19 (23.2%)
12 (14.6%)
21 (25.6%)
15 (18.3%)
29 (35.4%)
54 (73.0%)
19 (25.7%)
30 (40.5%)
40 (54.1%)
43 (58.1%)
27 (36.5%)
24 (32.4%)
16 (21.6%)
14 (18.9%)
9 (12.2%)
36 (39.1%)
63 (68.5%)
40 (43.5%)
24 (26.1%)
18 (19.6%)
20 (21.7%)
25 (27.2%)
21 (22.8%)
25 (27.2%)
6 (6.5%)
Seasonality 61 (75.3%) 59 (79.7%) 68 (74.7%)
Smoker in household 32 (41.6%) 23 (31.9%) 49 (53.3%)
Overall health status
Good, very good or excellent
Average
Bad or very bad
38 (46.3%)
33 (40.2%)
10 (12.2%)
38 (51.4%)
32 (43.2%)
4 (5.4%)
43 (46.7%)
45 (48.9%)
3 (3.3%)
Evolution since diagnosis
Improvement
No change
Deterioration
62 (76.5%)
16 (19.8%)
3 (3.7%)
58 (78.4%)
11 (14.9%)
5 (6.8%)
74 (81.3%)
14 (15.4%)
3 (3.3%)
a Replies are not mutually exclusive.
children in Algeria, 2 077 in Morocco and 2 870 in Tunisia,
whose parents were interviewed on their behalf. Of these
children, 106 in Algeria, 91 in Morocco and 102 in Tunisia
fulﬁlled criteria for asthma. For 82 children in Algeria, 74
in Morocco and 92 in Tunisia, their parents accepted to
continue with the full asthma questionnaire. These 248
children make up the study population for this analysis
(Fig. 1), and corresponded to 146 boys (58.9%) and 102
girls (41.1%). In Algeria and Tunisia, there were nearly
twice as many boys as girls contributing to the survey,
whereas in Morocco, girls were slightly over-represented
(Table 1). The mean age of the children with asthma was
8.4±4.3 years, with no signiﬁcant difference being observed
between countries.
Asthma history and context
Children with asthma had received a diagnosis four years
previously (median) at the age of two years (median).
The diagnosis had been made by a specialist in the
majority of cases (61.4%). Although this was the case in
all three Maghreb countries, it was particularly remarkable
in Morocco, where only eleven children had been diagnosed
by a general practitioner (Table 1).
The most frequent initial presenting symptoms which had
led to the diagnosis of asthma were persistent cough (50.8%
of children), breathlessness (43.1%) and wheezing (38.7%).
However, some differences were seen between countries
with, for example, persistent cough being cited for 73.0%
of children in Morocco and breathlessness for 68.5% of
children in Tunisia. Around three-quarters of the children
presented seasonal asthma and 43.2% had a smoker in their
household. Exposure to tobacco smoke was notably high
in Tunisia (53.3% of children). The overall health status of
the children was considered good to excellent in 48.4% of
cases and bad or very bad in seventeen children only (6.9%).
Asthma symptoms were considered to have improved since
diagnosis in 78.9% of children (Table 1).
Prevalence of asthma in children
Crude prevalence rates for paediatric asthma in a general
population sample of children aged under sixteen years
were 4.1% [95% conﬁdence intervals: 3.3% to 4.8%] for
Algeria, 4.4% [95%CI: 3.5% to 5.3%] for Morocco and 3.5%
[95%CI: 2.9% to 4.2%] for Tunisia. In Algeria and Tunisia,
asthma was more common in boys than in girls, whereas in
Morocco, girls were more frequently affected (Fig. 2). No
major differences in prevalence were observed with respect
to age, although in all three countries, the ﬁve to nine year
age group was the most affected (Fig. 2).
Current asthma features
The majority (155 children; 63.0%) had experienced a
severe asthma attack, deﬁned as a severe bout of coughing,
breathlessness, chest tightness or wheezing, in the previous
year. This proportion ranged from 57.1% (52 children) in
Tunisia, through 60.8% (45 children) in Morocco to 71.6%
(58 children) in Algeria. However, the frequency of such
severe attacks in the previous year was less than one per
month for the majority of children in all countries (63.7%
overall).
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Fig. 2. Age and gender-speciﬁc prevalence rates for asthma in three participating countries with their 95% conﬁdence intervals.
Table 2. Respiratory symptoms in the previous four weeks a
Algeria
(N = 82)
Morocco
(N = 74)
Tunisia
(N = 92)
Persistent cough 45 (54.9%) 43 (58.1%) 53 (57.6%)
Breathlessness 38 (46.3%) 39 (52.7%) 46 (50.0%)
Persistent cold 42 (51.2%) 41 (55.4%) 34 (37.0%)
Blocked nose 44 (53.7%) 34 (45.9%) 37 (40.2%)
Wheezing 34 (41.5%) 36 (48.6%) 40 (43.5%)
Respiratory problems 49 (59.8%) 31 (41.9%) 28 (30.4%)
Chest tightness 37 (45.1%) 32 (43.2%) 27 (29.3%)
Rhinitis 26 (31.7%) 42 (56.8%) 20 (21.7%)
Nocturnal awakenings 28 (34.1%) 28 (37.8%) 26 (28.3%)
Cough with phlegm 20 (24.4%) 25 (33.8%) 25 (27.2%)
Bronchitis 20 (24.4%) 12 (16.2%) 11 (12.0%)
Sinusitis 1 (1.2%) 17 (23.0%) 16 (17.4%)
Pneumonia 5 (6.1%) 9 (12.2%) 4 (4.3%)
None 4 (4.9%) 1 (1.4%) 2 (2.2%)
a More than one response was possible.
The most frequent respiratory symptoms reported in
the children over the previous four weeks (Table 2) were
persistent cough (56.9% of children overall), breathlessness
(49.6%), persistent colds (47.2%) and blocked nose (46.4%).
Overall, 59.6% of children experienced episodes of
breathlessness at least once a week, and 43.0% had
been wakened during the night by respiratory symptoms
at least once a week (Fig. 3). Although no obvious
differences in symptom presentation between the three
participating countries were observed, the frequency
of breathlessness and nocturnal awakenings appeared
somewhat lower in Tunisia and somewhat higher in Morocco.
For breathlessness, this between-country difference was
signiﬁcant (p < 0.01; Fisher’s exact test).
Asthma severity was rated using an algorithm based
on the GINA severity criteria and categorised as severe
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Fig. 3. Frequency of breathlessness (left) and nocturnal awakenings (right) in the previous four weeks. Data are presented as the percentage of
respondents.
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Fig. 4. Asthma severity. Data are presented as the percentage of
respondents.
persistent, moderate persistent, mild persistent or inter-
mittent (Fig. 4). Overall, 56 children (22.8%) were rated as
severe persistent and 76 (30.9%) as intermittent. However,
between-country differences were observed, with children
in Tunisia being rated as less severe than those in Algeria or
Morocco (p < 0.01; Fisher’s exact test).
Impact of asthma
During the previous year, one hundred children (40.7%;
33 children in Algeria, 35 in Morocco and 32 in Tunisia)
had missed school at least once because of their asthma.
The mean number of days missed ranged from 4.9±5.9 in
Tunisia to 9.9±11.6 in Algeria. Of the 49 children who were
reported to participate in sports regularly, 17 (34.7%) were
unable to do so at least once in the previous month due to
their asthma.
Overall, 176 children (73.0%) were considered to be
handicapped in their everyday activities always or most
of the time (Fig. 5). Only 24 children (9.9%) were
rarely or never handicapped. There was some suggestion
that children in Tunisia were less handicapped than the
others, but this difference was not statistically signiﬁcant.
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Fig. 5. Handicap due to asthma. Data are presented as the percentage of
respondents.
Table 3. Asthma impact a
Algeria
(N = 82)
Morocco
(N = 74)
Tunisia
(N = 92)
Sport and leisure N = 45
10 (22.2%)
N = 42
17 (40.4%)
N = 73
35 (47.9%)
Normal physical activity N = 43
12 (27.9%)
N = 41
22 (53.6%)
N = 81
34 (41.9%)
Professional activities N = 6
3 (50.0%)
N = 18
8 (44.4%)
N = 37
13 (35.1%)
Social activities N = 57
10 (17.5%)
N = 48
21 (43.7%)
N = 83
37 (44.6%)
Sleep N = 75
19 (25.3%)
N = 63
26 (41.3%)
N = 88
38 (43.2%)
Lifestyle N = 68
9 (13.2%)
N = 32
10 (31.3%)
N = 79
24 (30.4%)
Household tasks N = 14
3 (21.4%)
N = 11
4 (36.4%)
N = 19
4 (21.1%)
a Data represent the number (%) of subjects providing information on
the given item (N) who replied ’very limited’ or ’quite limited’ on a
ﬁve-point Likert scale.
Signiﬁcant impact of asthma was reported over a wide
variety of activities (Table 3).
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Asthma control
Asthma control was approached through a series of
questions relating to ﬁve of the six GINA control criteria.
Overall, only 7.6% [95%CI: 4.8 11.8%] of children were
Table 4. Asthma control determined using an algorithm based on
the GINA criteria a
Asthma control level Algeria
(N = 82)
Morocco
(N = 74)
Tunisia
(N = 92)
Controlled 6 (7.9%) 2 (2.9%) 10 (11.0%)
Partially controlled 37 (48.7%) 25 (36.2%) 47 (51.6%)
Uncontrolled 33 (43.4%) 42 (60.9%) 34 (37.4%)
Missing data 6 5 1
a Data represent the number (%) of children with asthma in each control
category. If any criterion was not determined, the asthma control was not
attributed and the individual was classiﬁed as missing data.
considered to be controlled and 46.2% [39.9 52.6%] to be
uncontrolled (Table 4). Asthma control was best in Tunisia
and worst in Morocco. This inter-country difference was
signiﬁcant (p = 0.03; c2 test).
Use of healthcare resources
Thirty children (12.2%) had required hospitalisation for
their asthma in the previous year and 81 had made
at least one visit to an emergency department (32.9%).
Both hospitalisation and emergency department visits were
around twice as frequent in Algeria than in Morocco and
Tunisia (Table 5). Moreover, for the majority of children
(89.0%), it was necessary to call out a physician due to an
asthma attack on multiple occasions (median: three times
in the last twelve months).
Most children consulted a private community practice
for their asthma and were followed by a specialist.
Recourse to public community care providers (community
hospitals, rural dispensaries and polyclinics) was highest
in Algeria (28.8%). In Morocco, more children attended
private healthcare providers and consulted specialists than
in the other two countries. The frequency of physician
consultation for asthma was higher in Algeria, with
42.9% of children consulting a physician at least once
a month. In Morocco and Tunisia, <25% consulted this
frequently, and over a third of children only consulted
Table 5. Hospitalisations and consultations for asthma a
Algeria (N = 82) Morocco (N = 74) Tunisia (N = 92)
Hospitalisations
At least one
Mean number±SD*
17 (21%)
2.6±2
7 (9.5%)
1.2±0.4
6 (6.6%)
1.3±0.5
Emergency room visits
At least one
Mean number±SD*
38 (46.9%)
4.4 (± 6.3)
17 (23.0%)
1.6 (± 0.9)
26 (28.6%)
4.3 (± 11.4)
Family doctor call-outs
At least one
Mean number±SD*
70 (90.9%)
4.9 (± 5.2)
63 (91.3%)
3.6 (± 3.2)
77 (85.6%)
4.2±4.0
Routine care structure
University hospital
Community hospital
Rural dispensary
Community care centre (polyclinics)
Private hospital clinic
Private community practice
General practitioner
Specialist
4 (5.0%)
14 (17.5%)
5 (6.3%)
4 (5.0%)
2 (2.5%)
51 (63.8%)
30 (37.5%)
50 (62.5%)
4 (5.5%)
6 (8.2%)
3 (4.1%)
0 (0%)
4 (5.5%)
56 (76.7%)
13 (17.8%)
60 (82.2%)
13 (14.3%)
8 (8.8%)
13 (14.3%)
0 (0%)
3 (3.3%)
54 (59.3%)
21 (23.1%)
63 (69.2%)
Frequency of physician consultation
At least once a week
Once per month
6 11 times per year
3 5 times per year
1 2 times per year
Less than once a year
6 (7.8%)
27 (35.1%)
10 (13%)
10 (13%)
21 (27.3%)
3 (3.9%)
2 (2.8%)
13 (18%)
8 (11.1%)
16 (22.2%)
22 (30.6%)
11 (15.3%)
4 (4.4%)
17 (18.9%)
17 (18.9%)
21 (23.3%)
27 (30.0%)
4 (4.4%)
Follow-up visits
Programmed
Only if asthma causes problems
28 (35.4%)
51 (64.6%)
21 (29.6%)
50 (70.4%)
40 (44.0%)
51 (56.0%)
Peak ﬂow meter use
Aware of existence
During consultations
At home
20 (24.4%)
20 (24.4%)
1 (1.2%)
21 (28.4%)
20 (27.0%)
1 (1.4%)
36 (39.1%)
25 (27.2%)
4 (4.3%)
Pulmonary function testing 12 (15.6%) 4 (5.8%) 6 (6.7%)
Standardised evaluation form 9 (11. 7%) 8 (11.3%) 7 (7.7%)
Drafting of an action plan 20 (26.3%) 12 (17.4%) 19 (21.1%)
a Calculated for subjects with at least one event.
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Table 6. Treatments for asthma a
Algeria (N = 82) Morocco (N = 74) Tunisia (N = 92)
Short-acting b-agonists 37 (45.1%) 55 (74.3%) 39 (42.4%)
Long-acting b-agonists + corticosteroids 2 (2.4%) 6 (8.1%) 9 (9.8%)
Inhaled corticosteroids only 9 (11.0%) 17 (23.0%) 29 (31.5%)
Oral corticosteroids 28 (34.1%) 24 (32.4%) 18 (19.6%)
Oral antihistamines 9 (11.0%) 22 (29.7%) 17 (18.5%)
Other treatments 24 (29.3%) 26 (35.1%) 55 (59.8%)
a Multiple responses were possible.
2 to 3 times a week
Once or twice a day
3 times a day
Never
At least once a week
Children using relief medication (%)
0 10 20 30 40 6050
Fig. 6. Frequency of use of short-acting b-agonists as relief medication. Data are presented as the percentage of respondents.
once or twice a year or less. Consultations were more
frequently programmed in Tunisia than in Morocco.
During the consultation, peak expiratory ﬂow was
evaluated in 65 children (27.0%), at every visit in half
of these. Only one child in Algeria and Morocco, and
four in Tunisia, possessed a peak ﬂow meter for use at
home. Pulmonary function testing had been performed in
22 children (9.3%), but only once in ten of these. Physicians
used a standardised rating form for evaluating asthma in 24
children (10.0%) and drafted an asthma management action
plan for 51 children (21.7%).
Treatments
Short-acting b-agonists were used by 131 children (52.8%).
Their use was higher in Morocco (74.3%) compared to the
other two countries (Table 6). These medications were used
at least once a day by 84 children (35%). Children in Morocco
appeared to use relief medication more frequently than
those in Tunisia (Fig. 6).
Concerning prophylactic treatments, the most frequently
used were oral corticosteroids, used by seventy children
(28.2%). Prophylactic treatments recommended by GINA
(inhaled corticosteroids alone or in association with long-
acting b-agonists) were used by 67 children (27.0%). The
use of such treatments was higher in Tunisia (41.3%) than in
Morocco (31.1%) or Algeria (13.4%).
Discussion
The overall prevalence rate for paediatric asthma in the
general population of the three Maghreb countries ranged
from 3.5% in Tunisia to 4.4% in Morocco. These rates
are generally lower than those reported in the ISAAC
study, performed in the early 1990s 1. The latter study
reported twelve-month prevalence rates for wheeze in the
13 14 year old age group of 7.8% for Algiers, 9.9% for
Casablanca, 5.6% for Marrakech and 6.8% in Rabat. The
younger 6 7 year-old age group were not evaluated in
the Maghreb centres of the ISAAC study. This difference
between our ﬁndings and the ISAAC results is likely to
be explained by the higher prevalence rates observed in
urban centres (which constitutes the unique data source
for ISAAC) compared with rural areas, which are included
in the national prevalence rates provided in the AIRMAG
study 8,12.
In this sample of children with asthma in the Maghreb, the
principal ﬁnding was the relatively high impact of asthma on
their lives, three-quarters of the sample being handicapped
by their asthma all or most of the time, one quarter fulﬁlling
the GINA severity criteria for severe persistent asthma and
one third needing to be taken to an emergency department
because of their asthma in the previous year. Forty percent
took time off school in the previous year because of their
asthma and ﬁfty percent had to cancel planned sports
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activities in the previous month. Given this unsatisfactory
state of affairs, it is remarkable that for four out of ﬁve
children, asthma was considered to have improved since
ﬁrst diagnosed.
The most frequent asthma symptoms reported were
breathlessness and wheezing, with the majority of children
experiencing an episode of breathlessness at least once
a week. In addition, other respiratory symptoms were
frequent in these children, notably colds and related
symptoms, as well as persistent cough. This is consistent
with a wealth of evidence for an association between
rhinitis and asthma 13.
Even though they did not appear to present more frequent
or severe symptoms than the other children in the study,
the children from Algeria were hospitalised and taken to
an emergency department twice as often as children from
Morocco or Tunisia. This may reﬂect the more important
role played by the public healthcare sector, with access to
care being in general free, in Algeria compared to the other
two countries. This could also explain certain of the other
inter-country differences observed, such as the higher use
of public community-based care structures in Algeria, and
the younger age at which asthma was diagnosed.
The severity of asthma identiﬁed in this study may
well be underestimated. Indeed, the algorithm for the
deﬁnition of severity assigns an overall severity grade on
the basis of the most severe rating reported for any on
the ﬁve items considered. Since data on two of these
items (exercise-induced symptoms and symptom frequency
during atypical weeks) were not collected in the AIRMAG
study, the overall severity assignment was made on the
basis of only three items (frequency of daytime symptoms,
frequency of night-time symptoms and frequency of severe
episodes in the last twelve months). It is likely that some
children would have fulﬁlled criteria for a more severe
grade on one of the missing items and thus may be
assigned to an inappropriately low severity grade on the
basis of the items actually evaluated. It is of interest
that some differences in the distribution of severity grades
were apparent between countries, notably for children in
Tunisia who appeared to present less severe asthma. This
may relate to differences in asthma management between
countries (see below).
The major impact of asthma in children from the Maghreb
that is apparent in this study, for example in the relatively
high rates of hospitalisation and emergency department
visits, is likely to reﬂect unsatisfactory asthma control. We
have attempted to address this issue by evaluating the
different variables contributing to the six criteria used to
deﬁne the level of asthma control in the GINA guidelines. It
was not possible to use the Asthma Control Test 14 to assess
control, as was done for adult participants in the AIRMAG
study, since this questionnaire has not been validated in
children. Using the GINA-based algorithm, we found less
than one child in twelve to be controlled and nearly half
to be uncontrolled. Asthma control appeared to be best
in Tunisia. Nonetheless, the level of control in this study
is likely to be over-estimated since pulmonary function
testing, which is included in the GINA criteria, was not
evaluated in the AIRMAG study. It has been shown previously
that exclusion of this criterion and reliance on symptoms
only when assessing asthma control in children results in
a signiﬁcant proportion of poorly controlled children being
incorrectly identiﬁed as controlled 15.
Several studies have shown convincingly that asthma
control can be improved by appropriate treatment 16. For
example, in a prospective observational study of 310
newly-diagnosed patients in seven centres in developing
countries 17, including two centres in Algeria and one in
Morocco, managed with a standardised protocol based on
GINA guidelines and treated with inhaled corticosteroids,
the proportion of patients falling into the lowest severity
grade (intermittent) rose form 11% to 55%. In the AIRMAG
study, however, less than one-third of the children assessed
were treated with inhaled corticosteroids. Cost has been
reported to limit accessibility to these medications in
many low- or middle-income countries 18,19, but recent GINA
reports have emphasised the need to improve accessibility
to essential drugs for the management of asthma in such
countries as a means to lowering barriers to achieving
satisfactory asthma control 20. The relatively high level of
use of oral corticosteroids may reﬂect the severity and poor
control of asthma in children from the Maghreb.
Other management strategies recommended by GINA,
which have less important cost implications, were also
found to be used infrequently in the management of
children with asthma in the Maghreb. These include the
planning of regular follow-up visits with the physician,
the drafting of a written action plan for handling severe
attacks, use of a peak ﬂow meter and regular pulmonary
function testing. This situation does not seem to have
improved since the need for improvement in these areas
was noted over a decade ago 21. All these actions contribute
to monitoring the care of the child with asthma and permit
timely adaptation of treatment whenever necessary 19. In
the absence of pulmonary function testing, asthma control
is likely to be over-estimated if evaluated from symptoms
alone 15,22. It is noteworthy that physician consultations
were more often planned in advance, awareness of
peak ﬂow meter use higher, and prescription of inhaled
corticosteroids more frequent, in Tunisia than in the
other countries, which may contribute to the apparently
lower severity of asthma and superior asthma control in
Tunisian children.
Finally, exposure to tobacco smoke causes children to
develop asthma and aggravates symptoms 23. We found that
43.2% of children with asthma in the AIRMAG population
had a smoker living with them in the household. This
is a higher proportion than smoking rates in the general
population (25.2% in Algeria, 18.1% in Morocco and 34.8%
in Tunisia 24), reinforcing the association between passive
smoking and childhood asthma. There is clearly a need
to highlight the potential impact of smoking on children’s
health, particularly with regard to asthma, in public health
campaigns aimed at smoking prevention in the Maghreb.
In conclusion, asthma has a major impact on the lives
of children with asthma in the Maghreb. This could be
attenuated by more widespread application of improved
standards of care, for example as promoted in the GINA
guidelines. It is necessary to educate both physicians and
people caring for children with asthma on the importance of
providing appropriate care and on the beneﬁts for children
with asthma that could be achieved in this way.
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